1. Home
  2. AORT vs HCM Comparison

AORT vs HCM Comparison

Compare AORT & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artivion Inc.

AORT

Artivion Inc.

HOLD

Current Price

$43.48

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo HUTCHMED (China) Limited

HCM

HUTCHMED (China) Limited

HOLD

Current Price

$16.03

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AORT
HCM
Founded
1984
2000
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.4B
IPO Year
1993
N/A

Fundamental Metrics

Financial Performance
Metric
AORT
HCM
Price
$43.48
$16.03
Analyst Decision
Strong Buy
Sell
Analyst Count
5
1
Target Price
$49.36
$13.75
AVG Volume (30 Days)
304.0K
59.0K
Earning Date
02-23-2026
08-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.53
Revenue
$422,646,000.00
$602,197,000.00
Revenue This Year
$15.97
N/A
Revenue Next Year
$10.96
$15.54
P/E Ratio
N/A
$5.89
Revenue Growth
9.81
N/A
52 Week Low
$21.97
$11.51
52 Week High
$48.25
$19.50

Technical Indicators

Market Signals
Indicator
AORT
HCM
Relative Strength Index (RSI) 40.55 75.72
Support Level $41.82 $14.63
Resistance Level $45.99 $15.00
Average True Range (ATR) 1.38 0.42
MACD -0.28 0.26
Stochastic Oscillator 33.07 90.63

Price Performance

Historical Comparison
AORT
HCM

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

Share on Social Networks: